文献速递外周动脉疾病

德国慢性肾脏病合并严重肢体缺血患者下肢旁路手术的长期结局

Long-Term Outcome of Lower Extremity Bypass Surgery in Patients with Chronic Kidney Disease and Critical Limb Ischemia in Germany.
PubMed 文献 · Ann Vasc Surg · 2024-07-14

基于德国AOK保险2010至2015年22,633例下肢旁路手术患者的回顾性分析,按CKD分期和PAD Fontaine分期比较围手术期及长期结局。CKD 4/5期60天死亡率19.8%,PAD IV期10.3%;PAD IV期与CKD 4/5期均独立预测长期生存不良。

要点

  • CKD 1/2期、3期、4/5期患者60天死亡率分别为7.2%、12.4%、19.8%。
  • PAD IV期患者围手术期死亡率10.3%,显著高于III期的4.5%。

核心结论

  • CKD和PAD分期同为患者生存和主要不良心血管事件的显著独立预测因素,PAD和CKD分期越高长期结局越差。

研究设计与样本

  • 回顾性分析德国AOK全国保险数据库2010至2015年接受下肢旁路手术的22,633例患者(14,523例男性),其中CKD 1/2期18,271例、CKD 3期2,483例、CKD 4/5期1,879例。

主要发现

  • 围手术期(60天)死亡率:CKD 1/2期7.2%,CKD 3期12.4%,CKD 4/5期19.8%。
  • 围手术期死亡率PAD IV期10.3% vs PAD III期4.5%,PAD IV期显著更高。
  • 术后长达9年Kaplan-Meier估计生存率:CKD 1/2期31.7%,CKD 3期14.3%,CKD 4/5期仅10.1%(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study is to present short- and long-term outcomes after lower extremity bypass (LEB) surgery in patients with chronic limb-threatening ischemia and chronic kidney disease (CKD), differentiated by peripheral artery disease (PAD) Fontaine stage III and IV. METHODS: Retrospective analysis of anonymized data from a nationwide German health insurance company (AOK). Data from 22,633 patients (14,523 men) who underwent LEB from 2010 to 2015 were analyzed, presenting 18,271 with CKD stage 1/2, 2,483 patients with CKD stage 3, and 1,879 with CKD stage 4/5. RESULTS: Perioperative mortality (60-day mortality) was 7.2% for CKD stage 1/2, 12.4% for CKD stage 3, and 19.8% for CKD stage 4/5. Patients with PAD stage IV had significantly higher perioperative mortality (10.3%) than patients with PAD stage III (4.5%). The perioperative major amputation rate depended significantly on PAD stage IV (odds ratio [OR]: 2.57 confidence interval [CI]: 2.16-3.05, P < 0.001), the LEB level below the knee and crural/pedal (OR: 2.49 CI: 2.14-2.90, P < 0.001), CKD stage 4/5 (OR: 1.28, CI: 1.06-1.54, P = 0.009), and the presence of diabetes mellitus type 2 (OR: 1.19, CI: 1.05-1.36, P = 0.007). Kaplan-Meier estimated long-term survival of up to 9 years after surgery was 31.7% for patients with CKD stage 1 and 2, 14.3% for CKD stage 3, and only 10.1% for CKD stage 4 and 5 (P < 0.001). PAD Fontaine stage IV versus III (hazard ratio: 1.64, CI: 1.56-1.71, P < 0.001), but not bypass level, had an independent adverse influence on long-term survival. CONCLUSION: CKD and PAD stage were equally significant independent predictors of patient survival and major adverse cardiovascular events with higher PAD and CKD stages associated with less favorable long-term outcomes.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Meyer P, Surmann J, Epple J, et al. Long-Term Outcome of Lower Extremity Bypass Surgery in Patients with Chronic Kidney Disease and Critical Limb Ischemia in Germany. Ann Vasc Surg. 2024. PMID: 39009125. doi:10.1016/j.avsg.2024.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。